Literature DB >> 7520106

Relative concentrations of endotoxin-binding proteins in body fluids during infection.

S M Opal1, J E Palardy, M N Marra, C J Fisher, B M McKelligon, R W Scott.   

Abstract

Endotoxin initiates the systemic inflammatory response, haemodynamic changes, and multi-organ failure that may occur as a consequence of systemic gram-negative bacterial infection. The serum protein lipopolysaccharide-binding protein (LBP) binds to the lipid A component of bacterial endotoxin and facilitates its delivery to the CD14 antigen on the macrophage, where inflammatory cytokines are released and a cascade of host mediators is initiated. The neutrophil granular protein bactericidal/permeability-increasing protein (BPI) competes with LBP for endotoxin binding and functions as a molecular antagonist of LBP-endotoxin interactions. We have measured concentrations of both proteins in body fluids from 49 consecutive patients. In 16 of 17 samples of fluid from closed-space infections, BPI was present in greater concentration than LBP (median BPI/LBP ratio 7.6 [95% CI 2.32-22.1]). The ratio of BPI and LBP was not significantly different from 1.0 in abdominal fluid from 10 patients with peritonitis (ratio 0.235 [0.18-0.47]), whereas the BPI/LBP ratio was low in 22 non-infected body fluids (0.01 [0.001-0.04]) and concentrations of both proteins approached those in normal human plasma. BPI concentrations were directly correlated with the quantity of neutrophils within clinical samples (rs = 0.81, p < 0.0001). Thus, within abscess cavities BPI is available in sufficient quantities for effective competition with LBP for endotoxin. BPI may attenuate the local inflammatory response and the systemic toxicity of endotoxin release during gram-negative infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520106     DOI: 10.1016/s0140-6736(94)91767-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

Review 1.  A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.

Authors:  O Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 2.  The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.

Authors:  Hendrik Schultz; Jerrold P Weiss
Journal:  Clin Chim Acta       Date:  2007-07-13       Impact factor: 3.786

Review 3.  Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.

Authors:  S M Opal; R L Yu
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

4.  LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.

Authors:  N Lamping; R Dettmer; N W Schröder; D Pfeil; W Hallatschek; R Burger; R R Schumann
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials.

Authors:  Thormika Keo; Jennifer Collins; Pratima Kunwar; Martin J Blaser; Nicole M Iovine
Journal:  Virulence       Date:  2011-01-01       Impact factor: 5.882

6.  The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome.

Authors:  A Myc; J Buck; J Gonin; B Reynolds; U Hammerling; D Emanuel
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

7.  Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.

Authors:  Y Weinrauch; A Foreman; C Shu; K Zarember; O Levy; P Elsbach; J Weiss
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates.

Authors:  Katheryn E Nathe; Richard Parad; Linda J Van Marter; Cara A Lund; Eugénie E Suter; Sonia Hernandez-diaz; Elizabeth B G Boush; Eva Ikonomu; Leighanne Gallington; Jo Ann Morey; Alenka M Zeman; Meaghan Mcnamara; Ofer Levy
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

9.  Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin.

Authors:  Eva C Guinan; Christine D Palmer; Christy J Mancuso; Lisa Brennan; Liat Stoler-Barak; Leslie A Kalish; Eugenie E Suter; Leighanne C Gallington; David P Huhtelin; Maria Mansilla; Ralf R Schumann; Jeffrey C Murray; Jerrold Weiss; Ofer Levy
Journal:  Innate Immun       Date:  2013-10-09       Impact factor: 2.680

10.  Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsis.

Authors:  S M Opal; J E Palardy; J W Jhung; C Donsky; R L Romulo; N Parejo; M N Marra
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.